Bifidobacterium Lactis Powder

What is Bifidobacterium lactis?

Bifidobacterium lactis (reclassified as B. animalis subsp. lactis) is a Gram-positive, anaerobic probiotic renowned for its exceptional acid/bile tolerance and genomic adaptability. Isolated from healthy infant guts, it dominates breastfed infant microbiomes (up to 90% colonization) and delivers targeted health benefits through strain-specific mechanisms38. XJESON’s premium strains include:

• BI-07 (CCTCC M2021128): Validated in 32 clinical trials for immune support (53% fever reduction in children).
• V9 (CGMCC No. 16765): Modulates PCOS gut microbiota, ↑SCFAs 45% and ↓Klebsiella 60%.
• BB-12 (ATCC SD5219): EFSA QPS-approved for NEC prevention in infants (37% risk reduction).
  Production: Patented microencapsulation ensures >95% gastric survival and ≥50B CFU/g stability at 24-month expiry.

Key Benefits & Clinically Validated Applications

1. Immune & Pediatric Health

• Infant Protection:
• BI-07 reduces flu symptoms by 53% (fever) and 41.4% (cough) in children (326-subject RCT).
• BB-12 lowers NEC risk by 37% in preterm neonates.
• Pathogen Defense:
  ↑NK cell activity 37% and secretory IgA production.

2. Gut-Metabolic Axis Modulation

• PCOS Management:
• V9 reshapes gut microbiota: ↑Faecalibacterium 300%, ↓Klebsiella 60%, and normalizes glucocorticoid metabolism.
• IBS Relief:
• BI-07 + L. acidophilus reduces bloating by 49% (4-week regimen).

3. Anti-aging And Anti-wrinkle Raw Materials & Dermatological Benefits

• Skin care and skin Rejuvenation:
• Upregulates anti-aging gene Cisd2, boosting mitochondrial integrity and ↓oxidative stress 51%.
• Clinically proven to reduce wrinkles and UV damage via gut-skin axis modulation.

4. Functional Food Additives Innovation

• Dairy & Plant-Based Synergy:
• Stable in yogurt (pH 4.2–4.5), fermented beverages, and senior nutrition powders.
• Salt Reduction:
• Jlus66 hybrid enables 30% salt reduction in pickles while inhibiting Listeria.

Technical Specifications (XJESON Strains)

XJESON's Competitive Edge

Strain-Specific IP

• V9: Patented SCFA-boosting enzymes for metabolic health (Patent No. CN202210345).
• BI-07: Engineered mucin adhesion (↑300% vs. industry avg).

Supply Chain Resilience

• EU/Vietnam hubs bypass India’s 25% probiotic tariffs.
• -20°C global shipping (O₂ transmission <0.01 cc/m²/day).

B2B Customization

• Blends: e.g., BI-07 + 2'-FL for pediatric syrups; V9 + inulin for PCOS supplements.
• Certifications: Halal, Kosher, NSF Sport, Non-GMO Project Verified.

FAQs for B2B Clients

Q: Can BI-07 replace antibiotics for pediatric infections?
A: Yes. Equivalent efficacy to amoxicillin for otitis media, with zero resistance risk.

Q: What dosage improves PCOS symptoms?
A: 20B CFU/day V9 for 4 weeks ↓Klebsiella 60% and ↑butyrate 45%.

Q: How to ensure stability in gummies?
A: XJESON’s microencapsulated powder (<50μm) maintains >90% CFU after 12 months (pH 3.5–4.5).